Vasopeptidase inhibitors--concepts and evidence.
Ruschitzka
F
F
Corti
R
R
Quaschning
T
T
Hermann
M
M
Lüscher
T F
TF
D000799:Angioedema / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D045283:Natriuretic Agents / Q000502:physiology; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000378:metabolism; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D045283:Natriuretic Agents; D011480:Protease Inhibitors; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; D015260:Neprilysin